Fig. 8From: Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysisRelative risk in patients with RA compared to those with other autoimmune rheumatologic diseases: (A) flare; (B) new-onset irAEs; (C) ORR; (D) DCR. ORR: objective response rate; DCR: disease control rateBack to article page